Disclosures: Rosa Lombardi: Nothing to Disclose, Roberta Forlano: Nothing to Disclose, Annalisa Cespiati: Nothing to Disclose, Felice Cinque: Nothing to Disclose, Gabriele Maffi: Nothing to Disclose, Paola Dongiovanni: Nothing to Disclose, Daniela Bignamini: Nothing to Disclose, Paolo Francione: Nothing to Disclose, Giordano Sigon: Nothing to Disclose, Jian Huang: Nothing to Disclose, Pinelopi Manousou: Nothing to Disclose, Flora Peyvandi: Nothing to Disclose, Armando Tripodi: Nothing to Disclose, Anna Fracanzani: Nothing to Disclose 609 ANALYSIS OF CARDIOVASCULAR RISK FACTORS DURING THE TREATMENT OF METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE WITH A LOW CARBOHYDRATE DIET Kwan Kit Cheung 1 Hongbo Du 1 , 1 Dongzhimen Hospital, Beijing University of Chinese Medicine Background: This study aimed to analyze cardiovascular risk factors during the treatment of metabolic dysfunction-associated fatty liver disease (MAFLD) with a low-carbohydrate diet
This evolving understanding of the distinct biochemical roles of L- and D-lactate has transformed the reputation of lactate from a mere marker of anaerobic metabolism to a critical regulator of cellular homeostasis, intercellular communication, and immune responses
From that viewpoint, infection of vertebrates is the main role for transmission of the spirochetes to another arthropod host, in this case soft-bodied (argasid) ticks of the genus Ornithodoros (Cooley and Kohls, 1944
The cDNAs of three HIF -subunits were cloned from RNA of primary rat hepatocytes by reverse transcriptase PCR [97]
D.PopkoB
